GL1X · GenesisL1 explorer

MolNFT v1 · #79987 · protein

Co-crystal structure of JAK2 with thienopyridine 19

3TJD · Tyrosine-protein kinase JAK2: “Co-crystal structure of JAK2 with thienopyridine 19”. X-ray diffraction, 1 ligand (6TP), 4 pockets (best druggability 0.74). MolNFT v1 #79987 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3TJD
Type
protein
Length
575 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
6TP
Pockets
4 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28644% helix, 18% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28941% helix, 19% strandO60674

Ligands and binding sites

  • 6TP · 4-amino-2-[4-(tert-butylsulfamoyl)phenyl]-N-methylthieno[3,2-c]pyridine-7-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16490.740.81716TP
25990.730.81556TP
35690.690.7846empty
4780.320.7418empty

Interfaces

1 interface between chains.

  • A–B · 545 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 3TJD · co-crystal structure of Jak2 with thienopyridine 19 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.